3fci: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
[[Image:3fci. | [[Image:3fci.png|left|200px]] | ||
<!-- | <!-- | ||
| Line 12: | Line 12: | ||
===Complex of UNG2 and a fragment-based designed inhibitor=== | ===Complex of UNG2 and a fragment-based designed inhibitor=== | ||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_19396178}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 19396178 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_19396178}} | |||
==About this Structure== | ==About this Structure== | ||
3FCI is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FCI OCA]. | 3FCI is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FCI OCA]. | ||
==Reference== | |||
<ref group="xtra">PMID:19396178</ref><references group="xtra"/> | |||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Amzel, L M.]] | [[Category: Amzel, L M.]] | ||
| Line 35: | Line 44: | ||
[[Category: Uracil dna glycosylase]] | [[Category: Uracil dna glycosylase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jun 3 10:06:21 2009'' | ||
Revision as of 10:06, 3 June 2009
Complex of UNG2 and a fragment-based designed inhibitorComplex of UNG2 and a fragment-based designed inhibitor
Template:ABSTRACT PUBMED 19396178
About this StructureAbout this Structure
3FCI is a 1 chain structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Chung S, Parker JB, Bianchet M, Amzel LM, Stivers JT. Impact of linker strain and flexibility in the design of a fragment-based inhibitor. Nat Chem Biol. 2009 Jun;5(6):407-13. Epub 2009 Apr 26. PMID:19396178 doi:10.1038/nchembio.163
Page seeded by OCA on Wed Jun 3 10:06:21 2009